The Union health ministry on Wednesday dismissed media reports claiming there was dissent from technical experts about increasing the gap between two Covishield doses and said the decision was based on scientific reason about the behaviour of adenovector vaccines.
The Centre on Saturday night announced that the probe into alleged irregularities in the medical entrance exam NEET will be handed over to the CBI for a comprehensive investigation.
An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.
The minister said he was not supposed to say anything officially as he was still in touch with the union health ministry and the ICMR officials.
Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.
An official of the fire and emergency services department said that 11 fire tenders including one each from Panchkula and Mohali were pressed into service to quickly control the blaze.
The American Association of Physicians of Indian Origin will attend the Pravasi Bharatiya Divas in Delhi with an agenda to develop a plan to bring together AAPI, NGOs and the government to provide access to affordable and quality health care. Aziz Haniffa reports
The vaccine candidate -- 'Covaxin' -- is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Groundbreaking HIV researcher Dr Suniti Solomon, the first to bring to the world the prevalence of the infection in India in 1986 and one who successfully led research into the treatment of the deadly virus, passed away at her residence in Chennai on Tuesday.
The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care.
The Supreme Court Thursday appreciated the Centre's step to grant ex gratia assistance to the kin of those who died due to COVID-19 saying it has to take judicial notice of the fact that what India has done, no other country has been able to do.
Family members of people who committed suicide within 30 days of being diagnosed with COVID-19 will be entitled to Rs 50,000 ex-gratia assistance as per the guidelines, the Centre told the Supreme Court on Thursday.
Eighteen patients have died in the last 24 hours at the Chhatrapati Shivaji Maharaj Hospital in Kalwa in Thane, civic commissioner Abhijit Bangar said on Sunday.
The ministry of education is yet to take call on the recommendations by the empowered expert committee and the University Grants Commission.
The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.
According to a study done by Singapore University of Technology and Design Data, coronavirus will 100 per cent end across the world on December 8.
The institute expects to complete both, phase-2 and 3 trials in India by the end of this year.
Ramdev's herbal medicine company Patanjali Ayurved has launched 'Coronil tablet and Swasari vati' medicines claiming they can cure the highly contagious disease within seven days.
3,007 fresh cases of Omicron reported across 27 states and UTs.
The death toll climbed to 4,51,814 with 379 fresh fatalities, according to the data updated at 8 am.
'Antibodies remain in the blood for at least seven to nine months.'
Responding to a question, he said, "It may also deal with fake news, though there is no specific mention in this regard."
Vardhan said the ICMR is actively researching on reports of COVID-19 reinfection and although the number of such cases is negligible at this moment, the government is fully seized of the importance of the matter, the health ministry said in a statement.
The phase 3 clinical trial will cover around 28,500 subjects, aged 18 years and above, and it will be conducted in 21 sites across ten states, including Delhi, Mumbai, Patna and Lucknow.
Winter Games in Beijing has glaring security problems that could expose sensitive data to interception, according to a report
'Bharat is a name that is 7000 years old.' 'We are not saying the name of the country should be changed from India to Bharat; we only recommended that the stress should be on Bharat.'
'Seek medical help if after five days of the first symptom the fever has not subsided.'
'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'
As many as 11 children died on Saturday and until Friday the death toll stood at 60.
The procurement and distribution will be centralised though the government is yet to take a call on the initial number of doses that will be procured.
The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.
The Centre has started the process of identifying around 30 crore priority beneficiaries who will be given vaccine in the initial phase. The Centre will procure the vaccine directly and make it available free-of-cost for the priority beneficiaries.
The burgeoning death notices come amid apprehensions that the number of cases and casualties are being underreported for a variety of reasons.
The Union health ministry said West Bengal and Himachal Pradesh reported a casualty each on Monday, taking the total number of deaths to nine in the country due to COVID-19.
Parliamentary Affairs Minister Prahlad Joshi has said that 31 bills will be taken up in the monsoon session. Among these include the Digital Personal Data Protection Bill, 2023.
The plans also state that highly suspected cases testing negative on Rapid Antigen Test should be examined again using the gold standard RT-PCR test.
Alleging that the candidate vaccine was not safe, he has also sought cancelling approval for its testing, 'manufacture and distribution', failing which legal action would be taken.
The project involves development of a military-civil, dual-use airport; international container trans-shipment terminal; a gas, diesel, and solar-based power plant, and a township.
'There is a deep stigma or taboo attached to COVID-19 in rural areas.' 'People don't want to test because they fear social exclusion.' 'Even those who test positive may not reveal and not follow the quarantine protocol.'
The DCGI arrived at the conclusion on Wednesday based on the recommendations of an independent expert committee which has also opined that compensation should not be paid to the volunteer, they said.
